Clinical Trials Directory

Trials / Completed

CompletedNCT00795496

Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
University of Helsinki · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The investigators will contact 64 patients with atopic dermatitis (AD) who participated in a long-term tacrolimus ointment trial in Helsinki 10 years ago, and ask them to participate in this follow-up study. The investigators will do the same tests as 10 years ago, i.e. bronchial hyperreactivity, skin prick tests, serum-IgE, Mantoux-test (2 TU), and questionnaires about asthma and allergic rhinitis symptoms. The investigators also collect data about their AD medication during the last 10 years. The investigators hypothesis is that when the skin condition improves in patients with AD the brochial hyperreactivity improves. The investigators also want to study whether different treatments play a role in the development or resolution of bronchial hyperreactivity.

Detailed description

We will by letters and telephone contact all patients (n=64) who fulfill the inclusion criteria for this study. The testing in the study (bronchial hyperreactivity, skin prick testing, serum IgE) is cross-sectional, but we retrospectively collect data from the last 10 years about the skin condition and medication for atopic diseases.

Conditions

Interventions

TypeNameDescription
PROCEDUREHistamine provocationA dosimetric histamine challenge test in which the provocative dose of inhaled histamine producing a decrease of 15% in FEV1 is measured.
PROCEDURESkin prick testsSkin prick testing will be performed for: birch, timothy, mugwort, alder, pine, cat, dog, horse, house dust mite, Cladosporium herbarum.
PROCEDURESerum IgE blood testingOne blood test to measure total serum IgE
PROCEDUREMantoux-testingTuberculin (2 TU) s.c. on the forearm. The test is read after 72 hours.

Timeline

Start date
2008-11-01
Primary completion
2010-04-01
Completion
2010-08-01
First posted
2008-11-21
Last updated
2011-04-20

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00795496. Inclusion in this directory is not an endorsement.